Step 1 topics → Musculoskeletal, Skin, and Connective Tissue → Rheumatoid Arthritis

Rheumatoid Arthritis

USMLE Step 1 trap: Overestimates RF specificity and undervalues anti-CCP as the more specific RA antibody. RF is sensitive (~70–80%) but not specific for RA; anti-CCP antibodies are more specific and can be positive in seronegative (RF-negative) RA.

Rheumatoid arthritis is a chronic, symmetric, inflammatory polyarthritis driven by autoimmune destruction of synovial tissue — and USMLE Step 1 tests it at multiple levels. The most costly mistake: anchoring on RF as the gold standard diagnostic test, when anti-CCP is far more specific and is the key test when RF is negative. The core pathology is pannus formation — activated synovial fibroblasts and immune cells create an invasive tissue that enzymatically erodes cartilage and subchondral bone — and the exam expects you to know the immune mechanism (CD4+ T cells, HLA-DR4, TNF-α), the classic joint distribution (MCPs, PIPs, wrists with DIP sparing), and the biologic management step that requires TB screening first.

The exam also loves serology. RF gets all the attention, but it's actually the less specific test — anti-CCP (ACPA) is more specific and can be positive even when RF is negative. This is a high-yield distinction because Step 1 questions will give you a patient with classic RA symptoms and a negative RF, then ask what test would confirm the diagnosis. If you've anchored on RF as the gold standard, you'll miss it. Morning stiffness lasting more than one hour that improves with activity is a key differentiator from OA (which worsens with activity).

Extra-articular features are another favorite target. Rheumatoid nodules, Felty syndrome (RA + splenomegaly + neutropenia), Caplan syndrome (RA + pneumoconiosis), and AA amyloidosis all appear on boards. Management questions focus on DMARD sequencing — methotrexate is first-line, then biologics like TNF-α inhibitors — with a critical requirement that students frequently miss: latent TB screening with PPD or IGRA before starting any biologic therapy.

From real student decks
89%have cards covering this topic
78%have mature cards
1median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Rheumatoid factor is highly specific for RA and its absence rules out the diagnosis.
Right: RF is sensitive (~70–80%) but not specific for RA; anti-CCP antibodies are more specific and can be positive in seronegative (RF-negative) RA.
RF is present in only about 70–80% of RA patients, meaning a negative RF does not rule out the disease. More importantly, RF is not specific — it can be elevated in other autoimmune conditions, infections, and even healthy elderly individuals. Anti-CCP antibodies are far more specific for RA and are the key test when RF is negative or when you need to confirm the diagnosis.
Common mistake
Wrong: Cartilage destruction in RA results from mechanical wear like OA.
Right: In RA, activated synovial fibroblasts and macrophages form pannus tissue that enzymatically erodes cartilage and bone.
OA is a mechanical wear-and-tear disease where cartilage degrades from repetitive stress and aging. RA is fundamentally different: activated synovial fibroblasts and macrophages proliferate into pannus tissue that actively invades and enzymatically destroys cartilage and bone via proteases and cytokines like TNF-α and IL-1. The erosion is immune-mediated, not mechanical — which is why anti-inflammatory and immunosuppressive drugs (not joint offloading) are the treatment.
Common mistake
Wrong: RA affects DIP joints like OA.
Right: RA characteristically spares DIP joints and affects MCPs, PIPs, and wrists symmetrically.
DIP joint involvement is the hallmark of OA (Heberden's nodes) and psoriatic arthritis — not RA. RA characteristically spares the DIPs and instead targets MCPs, PIPs, and wrists in a symmetric distribution. This distinction is frequently tested: if a question shows DIP joint involvement, think OA or psoriatic arthritis, not RA.
Common mistake
Gap: Misses the requirement for latent TB screening before starting TNF-alpha inhibitors in RA
TNF-alpha inhibitors used in RA reactivate latent TB, so PPD or IGRA testing is mandatory before initiating biologic therapy.
TNF-α inhibitors (etanercept, infliximab, adalimumab) suppress a cytokine that is critical for maintaining the granulomas that contain latent Mycobacterium tuberculosis. Blocking TNF-α can disrupt these granulomas and cause reactivation of latent TB, which can be rapidly fatal. Before starting any biologic therapy in RA, you must screen with a PPD (tuberculin skin test) or IGRA — this is a non-negotiable Step 1 fact.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the immune mechanism of RA: how CD4+ T cell activation, HLA-DR4 association, and TNF-α-driven synovitis lead to pannus formation and joint erosion.
  2. Identify the characteristic joint distribution of RA — symmetric involvement of MCPs, PIPs, and wrists with notable sparing of DIP joints — and recognize the classic hand deformities (ulnar deviation, boutonnière, swan neck).
  3. Distinguish RA morning stiffness (>1 hour, improves with activity) from OA stiffness (brief, worsens with activity), and recognize systemic constitutional features like fatigue and weight loss.
  4. Know RF vs. anti-CCP: RF is sensitive but not specific; anti-CCP is more specific and confirms diagnosis in RF-negative (seronegative) RA. Recognize erosions and periarticular osteopenia on X-ray.
  5. Identify extra-articular manifestations of RA including rheumatoid nodules, Felty syndrome (RA + splenomegaly + neutropenia), Caplan syndrome (RA + pneumoconiosis nodules), and secondary AA amyloidosis.
  6. Know DMARD sequencing in RA management: start with methotrexate, escalate to biologics (TNF-α inhibitors) for refractory disease, and understand that latent TB screening is mandatory before initiating biologic therapy.

Can you avoid these mistakes?

A 42-year-old woman has 6 weeks of symmetric swelling and pain in her MCPs and PIPs bilaterally, with 90 minutes of morning stiffness that improves as the day goes on. RF comes back negative. What is the next most appropriate diagnostic test, and what would you expect to find?
On imaging of a patient with longstanding RA, you see joint space narrowing, periarticular osteopenia, and bony erosions at the MCP joints. A patient with longstanding knee OA also has joint space narrowing. What explains the periarticular osteopenia and erosions in RA but not in OA?
A patient with RA has been on methotrexate for 2 years with partial response. Her rheumatologist decides to start adalimumab (a TNF-α inhibitor). Before prescribing, what must be done, and why?
Match each finding to RA or OA: (1) DIP Heberden's nodes, (2) ulnar deviation of the fingers, (3) stiffness that worsens after prolonged activity, (4) symmetric MCP synovitis, (5) positive anti-CCP antibodies.

Related topics

Bone Cells and Matrix Endochondral vs Membranous Ossification Fracture Healing Stages Compartment Syndrome

See how your Anki deck covers this topic.

Upload your deck for a free audit →